A de novo non-coding mutation in the NR5A1 gene causes aberrant alternative splicing and reduces normal messenger RNA expression by approximately 75 percent, according to a case report published in Frontiers in Pediatrics. The investigation, conducted by researchers at institutions including Shenzhen University, Shenzhen Luohu Hospital Group, and The University of Manchester, examined a two-year-old patient presenting with gender ambiguity associated with a 46,XY disorder of sex development.
The NR5A1 gene encodes a transcription factor that plays a critical role in sex differentiation and adrenal development by regulating multiple downstream genes involved in reproductive and endocrine processes. While mutations in NR5A1 are established causes of adrenal insufficiency and disorders of sex development, the vast majority of previously identified pathogenic variants reside within the gene’s protein-coding regions. The identification of the de novo c.−16 + 1G > A variant highlights the contribution of non-coding alterations to this clinical spectrum.
To determine the functional pathogenicity and molecular mechanisms driving the non-coding variant, the investigators engineered in vitro minigene constructs. These experimental models incorporated the human exon 1, intron 1, and exon 2 sequences alongside their native splice junctions. The research team subsequently applied reverse transcription quantitative polymerase chain reaction assays to measure and compare transcript expression profiles between the wild-type sequence and the mutant construct.
The laboratory evaluations demonstrated that the c.−16 + 1G > A substitution disrupted normal pre-messenger RNA processing, inducing aberrant alternative splicing. This mis-splicing event introduced an unintended start codon within intron 1, triggering premature translation termination within exon 2 and generating a truncated protein distinct from canonical NR5A1. Furthermore, quantitative expression analysis confirmed that levels of normal NR5A1 transcript decreased by roughly 75 percent in the presence of the mutation.
Based on these functional data, the authors concluded that the non-coding variant may lead to loss of function, impairing testicular development while sparing adrenal function. The researchers noted that characterization of this splice-site alteration provides experimental evidence to assist in classifying non-coding NR5A1 variants and may help guide clinical management and diagnostic decision-making for patients with 46,XY disorders of sex development.
The peer-reviewed case report was formally accepted on 06 October 2026 after initial submission on 22 April 2026, appearing in Frontiers in Pediatrics under the Genetics of Common and Rare Diseases section. Research leadership was coordinated by corresponding authors Lijuan Kan and Tong Ou, working alongside primary contributor Huishuang Chen and co-authors Baoling Lai, Huiying Huang, William Hart, Wei Wu, and Xiaoqing Xu. The multidisciplinary collaboration connected clinical and laboratory investigators from the Third Affiliated Hospital at Shenzhen University, the Shenzhen Luohu Hospital Group Luohu People’s Hospital Medical Laboratory Center, the Shenzhen Luohu Hospital Group Luohu People’s Hospital, and the University of Manchester.
Subject of Research: Functional analysis of a novel non-coding NR5A1 splicing mutation in 46,XY disorder of sex development
Article Title: Case Report: A novel exon 1 splicing mutation in the non-coding region of the NR5A1 gene causing 46,XY disorders of sex development
Article References: Chen, H., Lai, B., Huang, H., Hart, W., Wu, W., Xu, X., Kan, L., & Ou, T. (2026). Case Report: A novel exon 1 splicing mutation in the non-coding region of the NR5A1 gene causing 46,XY disorders of sex development. Frontiers in Pediatrics, 14, Article 1862860. https://doi.org/10.3389/fped.2026.1862860
Image Credits: AI Generated
DOI: 10.3389/fped.2026.1862860
Keywords: NR5A1, disorders of sex development, 46,XY DSD, splicing mutation, minigene assay, pediatric genetics, transcription factors, gene expression, Case, Report, novel, exon
News Source: Harold Sullivan. (November 12, 2026). Novel Noncoding NR5A1 Splicing Mutation Linked to 46,XY Sex Development Disorder. Scienmag.



